Form 4 for PCVX Vaxcyte, Inc.
Accepted 2023-10-04 00:00:00 ET · period of report 2023-10-02 · accession 0001209191-23-051895 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2023-10-04 | 2023-10-02 | PCVX | Wassil Jim | COO | S - Sale+OE | $50.43 | -3,000 | 170.9K | -2% | -$151.3K |
| D | 2023-10-04 | 2023-10-02 | PCVX | Wassil Jim | COO | M - OptEx | $2.42 | +3,000 | 173.9K | +2% | +$7,260 |
| D | 2023-10-04 | 2023-10-02 | PCVX | Wassil Jim | COO | M - OptEx | $0.00 | -3,000 | 107.6K | -3% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-10-02 | S | D | 608 | $50.74 | 171,785 | D | — | — | (F3) The price reported is a weighted-average price. The shares were sold at prices ranging from $50.31 to $51.13. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price. |
| 2 | Common | Common Stock | 2023-10-02 | S | D | 1,542 | $49.69 | 172,393 | D | — | — | (F2) The price reported is a weighted-average price. The shares were sold at prices ranging from $49.19 to $50.075. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price. |
| 3 | Common | Common Stock | 2023-10-02 | M | A | 3,000 | $2.42 | 173,935 | D | — | — | |
| 4 | Common | Common Stock | 2023-10-02 | S | D | 850 | $51.56 | 170,935 | D | — | — | (F4) The price reported is a weighted-average price. The shares were sold at prices ranging from $51.39 to $51.875. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price. |
| 5 | Derivative | Stock Option (right to buy) | 2023-10-02 | M | D | 3,000 | $0.00 | 107,555 | D | $2.42 · — to 2029-12-16 | 3,000 Common Stock | (F5) 1/4 of the shares subject to the option vested on December 1, 2020, and 1/48 of the shares vest monthly thereafter. |